Clinical Trial Update: Losartan for Patients With COVID-19 Not Requiring Hospitalization [Phase 2]

View source ↗

Summary

Phase 2 trial update examining losartan for non-hospitalized COVID-19 patients; study completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection
• Respiratory Distress Syndrome
• Sars-cov Infection

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: University of Minnesota | Conditions: Corona Virus Infection, Acute Respiratory Distress Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2022-05-04